TrialSchizophrenia research2013

Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.

Stephen I Deutsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.